Inventor
Meinolf Thiemann
Inventor
Schriesheim, DE
Overview
Patents· 36 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
C07KPeptides27%
A61KPreparations for medical, dental or toiletry purposes19%
C12NMicroorganisms or enzymes19%
C07DHeterocyclic compounds3%
G01NInvestigating or analysing materials by determining their chemical or physical properties1%
PatentTitleYear
11,014,991Monoclonal anti-CD95L (cluster of differentiation 95 ligand) antibody202110,870,688Single-chain CD137-receptor agonist proteins202010,844,108Single-chain CD27-receptor agonist proteins202010,793,616Single-chain CD40-receptor agonist proteins202010,683,332Single-chain light receptor agonist proteins202010,683,338Single-chain TL1A receptor agonist proteins202010,640,543CD27 ligand (CD27L) single-chain fusion polypeptides202010,533,043Single-chain glucocorticoid-induced tumor necrosis factor receptor (GITR) agonist proteins202010,519,208CD40L single-chain fusion polypeptides and encoding nucleic acids201910,519,217CD27L collectin fusion proteins and encoding nucleic acids201910,428,154Monoclonal anti-CD95L antibody201910,370,441Nucleic acids encoding artificial signal peptides and methods of production thereof201910,118,953Glucocorticoid-induced tumor necrosis factor receptor ligand (GITRL) single-chain fusion polypeptides201810,000,550GITRL-collectin fusion proteins and encoding nucleic acids20189,908,928'Artificial signal peptide'20189,908,927'Single-chain trail-receptor agonist proteins'20189,725,495'CD27 single chain molecules and encoding nucleic acids'20179,657,083'Composition comprising a mixture of CD95-Fc isoforms'20179,527,897'CD40L collectin fusion proteins and encoding nucleic acid molecules'20169,469,681'Fusion proteins forming trimers'20169,434,783'Shortened CD95-Fc variant fusion proteins, nucleic acids and host cells thereof'20169,359,420'Single chain trail fusion polypeptides and encoding nucleic acids'20169,340,599'Single chain CD40L fusion polypeptides'20169,315,570'Composition comprising a mixture of CD95-Fc isoforms and methods of producing same'20169,212,211'Trail collectin fusion proteins'20158,921,519'Single chain fusion polypeptides comprising soluble light cytokine domains'20148,907,063'TNF superfamily collectin fusion proteins and encoding nucleic acids'20148,841,459'3-arylamino pyridine derivatives'20148,664,366'Fusion proteins forming trimers'20148,580,273'TNF superfamily member light fusion proteins'20138,524,911'3-arylamino pyridine derivatives'20138,450,460'Single-chain TNFSF fusion polypeptides'20138,383,774'Collectin fusion proteins comprising TNF or trail'20138,198,457'3-arylamino pyridine derivatives'20128,147,843'CD95L or trail fusion proteins'20127,956,191'3-arylamino pyridine derivatives'2011Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2011–2021Based in Schriesheim, DE· patent location history
2012–2016Patents assigned to APOGENIX GMBH (14)· patent assignee history
2012–2014Patents assigned to THIEMANN MEINOLF (7)· patent assignee history
2012–2014Patents assigned to GIEFFERS CHRISTIAN (5)· patent assignee history
2012–2014Patents assigned to HILL OLIVER (5)· patent assignee history
2012Based in Shriesheim, DE· patent location history
2016–2021Patents assigned to APOGENIX AG (23)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| APOGENIX AG | 23 | 2016–2021 |
| APOGENIX GMBH | 14 | 2012–2016 |
| THIEMANN MEINOLFself | 7 | 2012–2014 |
| GIEFFERS CHRISTIAN | 5 | 2012–2014 |
| HILL OLIVER | 5 | 2012–2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| Schriesheim, DE | 35 | 2011–2021 |
| Shriesheim, DE | 1 | 2012 |